Human Papillomavirus Genotyping is a Reliable Prognostic Marker of Recurrence for High-Grade Cervical Intraepithelial Neoplasia (CIN2-3) with Positive Margins after Loop Electrosurgical Excision Procedure
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0005593
- Lead Sponsor
- Chonnam National University Hospital Hwasun Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 181
Inclusion Criteria
(1) pathologically confirmed CIN2-3 by a LEEP;
(2) patients with both pre- and post-LEEP HR HPV test results from the hybrid capture II assay (HC2) (Digene Co, Gaithersburg, MD) and the HDC test; and
(3) women who received follow-up examinations for = 5 years.
Exclusion Criteria
patients with a residual CIN2-3 lesion that was confirmed within three months following the LEEP.
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HPV test
- Secondary Outcome Measures
Name Time Method cytology